Predictors of the response to combined therapy with phosphodiesterase-5 inhibitors and endothelin receptor antagonists in pulmonary arterial hypertension
A. GARCIA (Barcelona, Spain), I. Blanco (Barcelona, Spain), M. Lopez Meseguer (Barcelona, Spain), J. Domingo Morera (Zaragoza, Spain), C. Martin Ontiyuelo (Barcelona, Spain), O. Tura Ceide (Barcelona, Spain), I. Otero Gonzalez (A Coruña, Spain), P. Escribano Subías (Madrid, Spain), J. Albert Barberà (Barcelona, Spain)
Source: International Congress 2022 – Treatment of pulmonary arterial hypertension
Session: Treatment of pulmonary arterial hypertension
Session type: Thematic Poster
Number: 2686
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. GARCIA (Barcelona, Spain), I. Blanco (Barcelona, Spain), M. Lopez Meseguer (Barcelona, Spain), J. Domingo Morera (Zaragoza, Spain), C. Martin Ontiyuelo (Barcelona, Spain), O. Tura Ceide (Barcelona, Spain), I. Otero Gonzalez (A Coruña, Spain), P. Escribano Subías (Madrid, Spain), J. Albert Barberà (Barcelona, Spain). Predictors of the response to combined therapy with phosphodiesterase-5 inhibitors and endothelin receptor antagonists in pulmonary arterial hypertension. 2686
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|